Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
Original Article
G.K. Abou-Alfa, T. Meyer, A.-L. Cheng, A.B. El-Khoueiry, L. Rimassa, B.-Y. Ryoo, I. Cicin, P. Merle, Y. Chen, J.-W. Park, J.-F. Blanc, L. Bolondi, H.-J. Klümpen, S.L. Chan, V. Zagonel, T. Pressiani, M.-H. Ryu, A.P. Venook, C. Hessel, A.E. Borgman-Hagey, G. Schwab, and R.K. Kelley
N Engl J Med 2018;379:54-63
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, July 5, 2020 - 11:59pm.